Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Genzyme's CEO on the Hot Seat
TheStreet.com
Monday, August 31, 2009 - 1:58pm
tags:
Genzyme, Pharma CEOs
A Step Forward for Bayer
Yahoo/Zacks.com
Monday, August 31, 2009 - 1:57pm
tags:
Bayer, atrial fibrillation, Xarelto
Antidepressants show upside in economic downturn
Fierce Pharma
Monday, August 31, 2009 - 12:05pm
tags:
Cymbalta, antidepressants, Eli Lilly
New Merck Management: A Lot Like the Old Merck Management
WSJ Online
Monday, August 31, 2009 - 12:02pm
tags:
Merck, Schering Plough, reorganization
Genzyme's Clolar Could Face Delay
Yahoo/Zacks.com
Monday, August 31, 2009 - 12:01pm
tags:
Clolar, Genzyme, AML
CBO Says House Bill Boosts Seniors’ Drug Premiums
Bloomberg
Monday, August 31, 2009 - 11:02am
tags:
healthcare reform, Medicare
Analyst Says Lilly's A Loser
CNBC
Monday, August 31, 2009 - 10:57am
tags:
Eli Lilly, Effient, blood thinners
Ticker Shock: Bristol-Myers Feeling Effects of Plavix
Minyanville
Monday, August 31, 2009 - 10:56am
tags:
Plavix, Bristol-Myers Squibb
SDI Reports: Takeda Touts New Drugs to Managed Care
Reuters
Monday, August 31, 2009 - 9:10am
tags:
managed care, Takeda
New Blood Thinners Could Be Alternatives to Coumadin, Plavix
WSJ Online
Monday, August 31, 2009 - 8:59am
tags:
blood thinners, Coumadin, Plavix
Merck to form 5 divisions after Schering buyout
Google/AP
Monday, August 31, 2009 - 8:58am
tags:
Merck, Schering Plough, buyouts, reorganization
FDA Accepts Pozen's NDA For Vimovo - Update
RTT News
Monday, August 31, 2009 - 8:32am
tags:
Pozen, NDA, FDA, Vimovo, arthritis
Cardinal Health spinoff signals new direction
Google/AP
Monday, August 31, 2009 - 8:00am
tags:
Cardinal Health
New Study Shows Abnormal Lipid Levels are Highly Common in Statin-Treated Patients
Marketwatch
Monday, August 31, 2009 - 7:59am
tags:
statins
Interview with Access Pharma CEO: Updates and Outlook
Seeking Alpha
Monday, August 31, 2009 - 7:47am
tags:
Access Pharmaceuticals, Pharma CEOs
Sanofi’s Experimental Anti-Clot Drug Shows Promise
Bloomberg
Monday, August 31, 2009 - 7:45am
tags:
Sanofi, anticlotting, Otamixaban
Regulatory questions for Astra, Boehringer drugs
Reuters
Monday, August 31, 2009 - 7:44am
tags:
Boehringer Ingelheim, AstraZeneca, Pradaxa, Brilinta
Wyeth responds to criticism
FT.com
Monday, August 31, 2009 - 7:42am
tags:
Wyeth, HRT, Prempro, Premarin
Study could boost new Astra-Zeneca drug
Marketwatch
Monday, August 31, 2009 - 7:41am
tags:
AstraZeneca, Plavix, Brilinta
BioElectronics Announces Completion of Clinical Study -- Preparing FDA 510(K) Pre-Marketing Notifica
PR-USA.net
Sunday, August 30, 2009 - 9:49am
tags:
MorphoSys

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.